These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20507072)

  • 21. Regioselective phosphorylation of myo-inositol with BINOL-derived phosphoramidites and its application for protozoan lysophosphatidylinositol.
    Aiba T; Sato M; Umegaki D; Iwasaki T; Kambe N; Fukase K; Fujimoto Y
    Org Biomol Chem; 2016 Jul; 14(28):6672-5. PubMed ID: 27326923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix.
    Riley AM; Dozol H; Spiess B; Potter BV
    Biochem Biophys Res Commun; 2004 May; 318(2):444-52. PubMed ID: 15120621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
    Riley AM; Correa V; Mahon MF; Taylor CW; Potter BV
    J Med Chem; 2001 Jun; 44(13):2108-17. PubMed ID: 11405648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
    Safrany ST; Sawyer DA; Nahorski SR; Potter BV
    Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of the enantiomers of 6-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, structural analogues of myo-inositol 1,3,4,5-tetrakisphosphate.
    Horne G; Potter BV
    Chemistry; 2001 Jan; 7(1):80-7. PubMed ID: 11205029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of inositol-based antagonists for the D-myo-inositol 1,4,5-trisphosphate receptor.
    Keddie NS; Ye Y; Aslam T; Luyten T; Bello D; Garnham C; Bultynck G; Galione A; Conway SJ
    Chem Commun (Camb); 2011 Jan; 47(1):242-4. PubMed ID: 20938532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and iron binding studies of myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate, and iron binding studies of all myo-inositol tetrakisphosphates.
    Spiers ID; Barker CJ; Chung SK; Chang YT; Freeman S; Gardiner JM; Hirst PH; Lambert PA; Michell RH; Poyner DR; Schwalbe CH; Smith AW; Solomons KR
    Carbohydr Res; 1996 Feb; 282(1):81-99. PubMed ID: 8721738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group.
    Hirata M; Watanabe Y; Kanematsu T; Ozaki S; Koga T
    Biochim Biophys Acta; 1995 Jun; 1244(2-3):404-10. PubMed ID: 7599161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoselective alcoholysis/acetolysis of trans-ketals over cis-ketals and its application in the total synthesis of the cellular second messenger, D-myo-inositol-1,4,5-trisphosphate.
    Vidyasagar A; Pathigoolla A; Sureshan KM
    Org Biomol Chem; 2013 Sep; 11(33):5443-53. PubMed ID: 23851711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of myo-[3H]inositol trisphosphates found in myo-[3H]inositol prelabelled avian erythrocytes.
    Stephens LR; Hawkins PT; Downes CP
    Biochem J; 1989 Sep; 262(3):727-37. PubMed ID: 2590163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological properties of 2-substituted myo-inositol 1,4,5-trisphosphate analogues directed toward affinity chromatography and photoaffinity labeling.
    Ozaki S; Watanabe Y; Ogasawara T; Hirata M; Kanematsu T
    Carbohydr Res; 1992 Oct; 234():189-206. PubMed ID: 1468078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-glycoside based mimics of D-myo-inositol 1,4,5-trisphosphate.
    Rosenberg HJ; Riley AM; Correa V; Taylor CW; Potter BV
    Carbohydr Res; 2000 Oct; 329(1):7-16. PubMed ID: 11086681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.
    Terauchi M; Abe H; Tovey SC; Dedos SG; Taylor CW; Paul M; Trusselle M; Potter BV; Matsuda A; Shuto S
    J Med Chem; 2006 Mar; 49(6):1900-9. PubMed ID: 16539376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective synthesis of trisubstituted olefins by a directed allylic substitution strategy.
    Schmidt Y; Breit B
    Chemistry; 2011 Oct; 17(42):11780-8. PubMed ID: 21887831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel cost-effective methanephosphonoanilidothioate approach to the stereoselective synthesis of dinucleoside (3',5')-methanephosphonates.
    Stec WJ; Woźniak LA; Pyzowski J; Niewiarowski W
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):381-95. PubMed ID: 9303190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xylopyranoside-based agonists of D-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity.
    Rosenberg HJ; Riley AM; Marwood RD; Correa V; Taylor CW; Potter BVL
    Carbohydr Res; 2001 May; 332(1):53-66. PubMed ID: 11403088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-myo-inositol-1,4,5-trisphosphate and adenophostin mimics: importance of the spatial orientation of a phosphate group on the biological activity.
    Roussel F; Moitessier N; Hilly M; Chrétien F; Mauger JP; Chapleur Y
    Bioorg Med Chem; 2002 Mar; 10(3):759-68. PubMed ID: 11814866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of analogues of myo-inositol 1,4,5-trisphosphate that contain sulfonamide, sulfate, methylphosphonate, and carboxymethyl groups.
    Westerduin P; Willems HA; van Boeckel CA
    Carbohydr Res; 1992 Oct; 234():131-40. PubMed ID: 1334798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.